Pr. Harris et al., RECOMBINANT HELICOBACTER-PYLORI UREASE ACTIVATES PRIMARY MUCOSAL MACROPHAGES, The Journal of infectious diseases, 178(5), 1998, pp. 1516-1520
Helicobacter pylori urease is absorbed into the gastric mucosa at site
s of inflammation, but whether the enzyme activates mucosal macrophage
s is not known. Because mucosal macrophages differ phenotypically and
functionally from blood monocytes, whether recombinant H. pylori ureas
e (rUrease) activated purified lamina propria macrophages in vitro was
investigated. rUrease (1-10 mu g/mL) induced primary mucosal macropha
ges to produce interleukin (IL)-1 beta, IL-6, and tumor necrosis facto
r (TNF)-alpha but not IL-8 proteins in a dose-dependent manner (P < .0
5 to P < .001). Quantitative reverse transcriptase-polymerase chain re
action using capillary electrophoresis laser-induced fluorescence show
ed that rUrease (0.1-10 mu g/mL) also induced dose-dependent expressio
n of IL-1 beta, IL-6, and TNF-alpha but not IL-8 mRNA (P < .05), sugge
sting that rUrease-induced production of certain cytokines is regulate
d at the level of gene transcription. These findings indicate that the
ability of H. pylori urease to activate mucosal macrophages, resultin
g in production of proinflammatory cytokines, may be involved in the p
athogenesis of H. pylori-associated mucosal inflammation.